Annular Biotech is a biotechnology company that provides contract manufacturing and early-stage development of custom monoclonal antibodies (mAbs). Annular’s goal is to provide industry and academic researchers with high quality mAbs through a combination of development speed and optimization of epitope binding. Our focus is exceptional customer service starting at consultation through project completion to ensure we meet your specific needs. We offer the “ABitope Kit”, or a panel of mAbs that gives researchers the ability to utilize a diverse number of antibodies to assist in R&D, diagnostic and therapeutic applications.
Through no-fee consultation we develop custom solutions, saving the Client time and resources in the long-term
Our process facilitates improved discovery with the ability to discard insignificant hybridoma clones and measurably improve recovery of valuable clones
Our end product culminates in the ABitope Kit tailored to the unique requirements of the Client
NEWS & EVENTS
Annular offers improvements in the discovery of high-value hybridomas that ultimately provide mAbs of greater market value. This process results in panels of mAbs, otherwise known as the “ABitope Kit” with varying epitope specificities that can be exploited for numerous applications. The benefits of our technology provides the Client with a competitive edge, reducing their project time and use of valuable resources.